Clinical study protocol for the ARCH project computational modeling for improvement of outcome after vascular access creation

Journal of Vascular Access

Volumn 12, Issue 4, 2011, Pages 369-376

  Bode, Aron ^a   Caroli, Anna ^b   Huberts, Wouter ^c   Planken, Nils ^d   Antiga, Luca ^b   Bosboom, Marielle ^c   Remuzzi, Andrea ^b,e   Tordoir, Jan ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

^c EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF BERGAMO   (Italy)

Author keywords

Arteriovenous fistula; Clinical protocols; Computer simulation; Hemodynamics

Indexed keywords

ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL PROTOCOL; CLINICAL STUDY; CONTRAST ENHANCEMENT; FOLLOW UP; GOOD CLINICAL PRACTICE; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; LIFE EXPECTANCY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; SIMULATION; TREATMENT CONTRAINDICATION; VASCULAR ACCESS;

EID: 83455200759     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2011.8382     Document Type: Article

References (37)

1. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13 Suppl 1: S37-40.
2. Himmelfarb J, Berns A, Szczech L, Wesson D. Cost, quality, and value: the changing political economy of dialysis care. J Am Soc Nephrol 2007; 18(7): 2021-7.
3. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20(12): 2587-93.
4. Grassmann A, Gioberge S, Moeller S, Brown G. End-stage renal disease: global demographics in 2005 and observed trends. Artificial organs 2006; 30(12): 895-7.
5. Tordoir J, Canaud B, Haage P, et al. EBPG on Vascular Access. Nephrol Dial Transplant 2007; 22 Suppl 2: ii88-117.
6. Ikizler TA, Himmelfarb J. Trials and trade-offs in haemodialysis vascular access monitoring. Nephrol Dial Transplant 2006; 21(12): 3362-3.
7. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney international 2002; 62(4): 1109-24.
8. Roy-Chaudhury P, Spergel LM, Besarab A, Asif A, Ravani P. Biology of arteriovenous fistula failure. Journal of nephrology 2007; 20(2): 150-63.
9. Tordoir JH, Dammers R, van der Sande FM. Upper extremity ischemia and hemodialysis vascular access. Eur J Vasc Endovasc Surg 2004; 27(1): 1-5.
10. MacRae JM. Vascular access and cardiac disease: is there a relationship? Curr Opin Nephrol Hypertens 2006; 15(6): 577-82.
11. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37 (1 Suppl 1): S137-81.
12. Lin SL, Huang CH, Chen HS, Hsu WA, Yen CJ, Yen TS. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. American journal of nephrology 1998; 18(2): 96-100.
13. Konner K. Primary vascular access in diabetic patients: an audit. Nephrol Dial Transplant 2000; 15(9): 1317-25.
14. Sidawy AN, Gray R, Besarab A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002; 35(3): 603-10.
15. Silva MB, Jr., Hobson RW, 2nd, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27(2): 302-7; discussion 7-8.
16. Grodins FS. Integrative cardiovascular physiology: a mathematical synthesis of cardiac and blood vessel hemodynamics. Q Rev Biol 1959; 34(2): 93-116.
17. Vorp DA. Biomechanics of abdominal aortic aneurysm. Journal of biomechanics 2007; 40(9): 1887-902.
18. Breeuwer M, de Putter S, Kose U, et al. Towards patientspecific risk assessment of abdominal aortic aneurysm. Med Biol Eng Comput 2008; 46(11): 1085-95.
19. Les AS, Shadden SC, Figueroa CA, et al. Quantification of hemodynamics in abdominal aortic aneurysms during rest and exercise using magnetic resonance imaging and computational fluid dynamics. Annals of biomedical engineering; 38(4): 1288-313.
20. Tang BT, Cheng CP, Draney MT, et al. Abdominal aortic hemodynamics in young healthy adults at rest and during lower limb exercise: quantification using image-based computer modeling. American journal of physiology 2006; 291(2): H668-76.
21. David T, Moore S. Modeling perfusion in the cerebral vasculature. Med Eng Phys 2008; 30(10): 1227-45.
22. Cebral JR, Castro MA, Burgess JE, Pergolizzi RS, Sheridan MJ, Putman CM. Characterization of cerebral aneurysms for assessing risk of rupture by using patient-specific computational hemodynamics models. Ajnr 2005; 26(10): 2550-9.
23. Hunter PJ, Pullan AJ, Smaill BH. Modeling total heart function. Annu Rev Biomed Eng 2003; 5: 147-77.
24. Gijsen FJ, Wentzel JJ, Thury A, et al. A new imaging technique to study 3-D plaque and shear stress distribution in human coronary artery bifurcations in vivo. Journal of biomechanics 2007; 40(11): 2349-57.
25. Migliavacca F, Dubini G. Computational modeling of vascular anastomoses. Biomech Model Mechanobiol 2005; 3(4): 235-50.
26. Smye SW, Clayton RH. Mathematical modelling for the new millenium: medicine by numbers. Med Eng Phys 2002; 24(9): 565-74.
27. Taylor CA, Figueroa CA. Patient-specific modeling of cardiovascular mechanics. Annu Rev Biomed Eng 2009; 11: 109-34.
28. Lesage D, Angelini ED, Bloch I, Funka-Lea G. A review of 3D vessel lumen segmentation techniques: models, features and extraction schemes. Med Image Anal 2009; 13(6): 819-45.
29. Ene-Iordache B, Mosconi L, Remuzzi G, Remuzzi A. Computational fluid dynamics of a vascular access case for hemodialysis. J Biomech Eng 2001; 123(3): 284-92.
30. Ene-Iordache B, Mosconi L, Antiga L, et al. Radial artery remodeling in response to shear stress increase within arteriovenous fistula for hemodialysis access. Endothelium 2003; 10(2): 95-102.
31. Planken RN, Keuter XH, Kessels AG, Hoeks AP, Leiner T, Tordoir JH. Forearm cephalic vein cross-sectional area changes at incremental congestion pressures: towards a standardized and reproducible vein mapping protocol. J Vasc Surg 2006; 44(2): 353-8.
32. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243(1): 148-57.
33. Grobner T. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21(4): 1104-8.
34. Penfield JG, Reilly RF, Jr. What nephrologists need to know about gadolinium. Nature clinical practice 2007; 3(12): 654-68.
35. Miyazaki M, Lee VS. Nonenhanced MR angiography. Radiology 2008; 248(1): 20-43.
36. Gjesdal KI, Storaas T, Geitung JT. A noncontrast-enhanced pulse sequence optimized to visualize human peripheral vessels. Eur Radiol 2009; 19(1): 110-20.
37. Leiner T, Kucharczyk W. NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe. J Magn Reson Imaging 2009; 30(6): 1357-63.